In ESCC animal studies, the inhibition of CCL2-CCR2 axis could suppress tumor growth by blocking M2 macrophage recruitment and thus enhance the antitumor effect of CD8+ T cells [29]. This evidence concerns the gene CD8A and neoplasm.